Manchester United are edging towards the finish line in their pursuit of Ederson, with Fabrizio Romano confirming that all documents are now prepared...
Manchester United are edging towards the finish line in their pursuit of Ederson, with Fabrizio Romano confirming that all documents are now prepared and waiting for the final sign off. The agreement has been in place for roughly a month, yet there remains one final hurdle: the second part of the Brazilian midfielder's medical. It is a curious delay, but one that suggests due diligence rather than cold feet.Let us be clear about what this signing represents. Ederson is not a headline grabber in the mould of a Jude Bellingham or a Declan Rice, but he offers something United have lacked for years. Tactical flexibility. The ability to sit deep and screen a back four, to break up play and then shift the ball into transitional phases with speed and precision. At £35 million, this is a calculated investment in balance rather than glamour.Why the second medical It is not uncommon for clubs to split examinations into two phases, especially when there are minor concerns or complex contractual clauses to untangle. The first part likely covered the standard cardiovascular and muscular checks. The second part, often the more revealing, will drill down into historical injuries and long term durability. United have been burned before by players who arrived with hidden scars, and they are taking no chances here.The real question for supporters is whether Ederson can adapt to the Premier League's relentless tempo. He has shown composure in the air and a willingness to sit in a low block when required, but English football punishes hesitation. If he passes that final medical, United will have a player who can rotate with Casemiro and allow Kobbie Mainoo to push higher up the pitch. It is a signing built for the long haul, not for instant fireworks.One cannot help but wonder if this deal signals a shift in recruitment philosophy at Old Trafford. For years, the club chased stars and ended up with misfits. Now, they appear to be targeting profiles that fit a system, even if those profiles lack the usual box office appeal. That is a mature approach, and one that should steady the ship in the months ahead.For now, all eyes are on that second medical. Once it is completed, expect the announcement to follow swiftly. The paperwork is ready, the funds are allocated, and the player is waiting. It is squeaky bum time for the medical staff.
